A blockbuster cancer drug? TYK’s claims go under the microscope
The medicines company released scanty but promising results for an experimental drug just as its shares were joining the Hong Kong Stock Connect scheme Key Takeaways: The drug being developed…
Product Approval Breathes New Life Into Boan Biotech IPO
The biosimilar drug maker was approved to sell its second new product in China last month as it applies to list in Hong KongKey Takeaways:Boan Biotechnology has filed for a…
Recent Articles
RECENT ARTICLES
-
Cancer drug maker Genfleet joins Hong Kong IPO influx
-
Everest Medicines drives growth with AI-powered mRNA pipeline
1952.HK 50.80 (+3.1%)
-
AstraZeneca could face limited fallout from Chinese tax probe
AZN.US 71.71 (+1.7%)
- IPO pitch puts BrainAurora’s earnings under the microscope
-
NEWS WRAP: AstraZeneca China president assisting in investigation
AZN.US 71.71 (+1.7%)
